Haploidentical Transplantation (HAPLO) with Post-Transplant High-Dose Cyclophosphamide for Graft Vs Host Disease (GVHD) Prevention in the Treatment of High Risk Hematological Neoplasms

被引:0
|
作者
Gayoso, Jorge [1 ]
Kwon, Mi
Serrano, David [1 ]
Balsalobre, Pascual [1 ]
Anguita, Javier
Pascual, Cristina
Perez-Corral, Ana
Buno, Ismael [2 ]
Martinez-Laperche, Carolina [1 ]
Castilla-Llorente, Cristina [3 ]
Heras, Inmaculada [3 ]
Jesus Pascual, Maria [4 ]
Caballero, Dolores [5 ]
Luis Diez-Martin, Jose
机构
[1] Gregorio Maranon Gen Univ Hosp, Dept Hematol, Madrid, Spain
[2] Gregorio Maranon Hlth Res Inst IISGM, Madrid, Spain
[3] Hosp Gen Univ Morales Meseguer, Hematol & Clin Oncol Unit, Murcia, Spain
[4] Hosp Univ Carlos Haya, Malaga, Spain
[5] Hosp Univ Salamanca, Salamanca, Spain
关键词
D O I
10.1182/blood.V120.21.4545.4545
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4545
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Myeloablative Conditioning Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PTCy) As GvHD Prophylaxis in High Risk Leukemias/Myelosdysplastic Syndromes (MDS): Geth Experience
    Gayoso, Jorge
    Balsalobre, Pascual
    Kwon, Mi
    Herrera, Pilar
    Bermudez, Arancha
    Sampol, Antonia
    Jimenez, Santiago
    Lopez-Corral, Lucia
    Serrano, David
    Montesinos, Pau
    Pascual, Maria-Jesus
    Heras, Inmaculada
    Bento, Leyre
    Varela, Rosario
    Humala, Karem
    Zabalza, Amaya
    Laiglesia, Almudena
    Bastos-Oreiro, Mariana
    Perez-Corral, Ana
    Martinez-Laperche, Carolina
    Diez-Martin, Jose Luis
    [J]. BLOOD, 2016, 128 (22)
  • [32] HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH HIGH DOSE CYCLOPHOSPHAMIDE POST-TRANSPLANT IN HIGH RISK HEMATOLOGIC MALIGNANCIES: RISK FACTOR AND OUTCOME ANALYSES IN OUR CENTER
    Viedma, J.
    Saez-Perdomo, M.
    Perera, M.
    Suarez, A.
    Lopez, J.
    Medina, C.
    Guerra, L.
    Gomez-Casares, M. T.
    Luzardo, H.
    Molero, T.
    Jimenez, S.
    [J]. HAEMATOLOGICA, 2017, 102 : 862 - 863
  • [33] Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide
    Marco, Daniel N.
    Queralt Salas, Maria
    Gutierrez-Garcia, Gonzalo
    Monge, Ines
    Riu, Gisela
    Carcelero, Esther
    Ramon Roma, Joan
    Llobet, Noemi
    Arcarons, Jordi
    Suarez-Lledo, Maria
    Martinez, Nuria
    Pedraza, Alexandra
    Domenech, Ariadna
    Rosinol, Laura
    Fernandez-Aviles, Francesc
    Urbano-Ispizua, Alvaro
    Rovira, Montserrat
    Brunet, Merce
    Martinez, Carmen
    [J]. PHARMACEUTICALS, 2022, 15 (12)
  • [34] HLA-HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANT WITH HIGH-DOSE, POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR CHILDREN HEMATOLOGIC MALIGNANCIES
    Zhiy, P.
    Chunfu, L.
    Xuedong, W.
    Xiaoqin, F.
    Yuelin, H.
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : 148 - 148
  • [35] Haploidentical non-myeloablative bone marrow transplant with post-infusion high-dose cyclophosphamide as GvHD prophylaxis in high-risk patients
    Gayoso, J.
    Balsalobre, P.
    Serrano, D.
    Rodriguez-Macias, G.
    Kwon, M.
    Munoz, C.
    Anguita, J.
    Perez-Corral, A.
    Gomez-Pineda, A.
    Buno, I.
    Diez-Martin, J. L.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S400 - S400
  • [36] The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML
    Avichai Shimoni
    Myriam Labopin
    Emanuele Angelucci
    Didier Blaise
    Fabio Ciceri
    Yener Koc
    Zafer Gülbas
    J. L. Diez-Martin
    Benedetto Bruno
    Luca Castagna
    Massimo Martino
    Montserrat Rovira
    Mohamad Mohty
    Arnon Nagler
    [J]. Bone Marrow Transplantation, 2022, 57 : 384 - 390
  • [37] The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML
    Shimoni, Avichai
    Labopin, Myriam
    Angelucci, Emanuele
    Blaise, Didier
    Ciceri, Fabio
    Koc, Yener
    Gulbas, Zafer
    Diez-Martin, J. L.
    Bruno, Benedetto
    Castagna, Luca
    Martino, Massimo
    Rovira, Montserrat
    Mohty, Mohamad
    Nagler, Arnon
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (03) : 384 - 390
  • [38] Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients
    Brunello, Lucia
    Passera, Roberto
    Dellacasa, Chiara Maria
    Giaccone, Luisa
    Audisio, Ernesta
    Ferrero, Dario
    D'Ardia, Stefano
    Allione, Bernardino
    Aydin, Semra
    Festuccia, Moreno
    Lia, Giuseppe
    Crisa, Elena
    Maffini, Enrico
    Butera, Sara
    Busca, Alessandro
    Bruno, Benedetto
    [J]. ANNALS OF HEMATOLOGY, 2018, 97 (11) : 2205 - 2215
  • [39] Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients
    Lucia Brunello
    Roberto Passera
    Chiara Maria Dellacasa
    Luisa Giaccone
    Ernesta Audisio
    Dario Ferrero
    Stefano D’Ardia
    Bernardino Allione
    Semra Aydin
    Moreno Festuccia
    Giuseppe Lia
    Elena Crisà
    Enrico Maffini
    Sara Butera
    Alessandro Busca
    Benedetto Bruno
    [J]. Annals of Hematology, 2018, 97 : 2205 - 2215
  • [40] Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis
    Crocchiolo, R.
    Bramanti, S.
    Vai, A.
    Sarina, B.
    Mineri, R.
    Casari, E.
    Tordato, F.
    Mauro, E.
    Timofeeva, I.
    Lugli, E.
    Mavilio, D.
    Carlo-Stella, C.
    Santoro, A.
    Castagna, L.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (02) : 242 - 249